Association between Heterologous Prime-boost Vaccination and Coronavirus Disease 2019 Among People in Phayao Province: A Matched Case-Control Study
Keywords:
Vaccination, Heterologous prime-boost vaccination, Covid-19Abstract
Coronavirus disease 2019 is a respiratory disease that can cause severe illness if patients do not get COVID-19 vaccination. This research aimed to explore the association between heterologous prime-boost COVID-19 vaccination and COVID-19 incidence among people in Phayao province. This matched case-control study was conducted with a sample of 385 adults aged 18 years and over in Phayao province who were selected using the stratified two-stage random sampling method with a case/control ratio of 1:4 (77 cases and 308 controls). Data were collected in September 2022 and then analyzed for frequency, percentage, mean, standard deviation, and conditional logistic regression.
The results showed that getting a heterologous prime-boost COVID-19 vaccination was significantly associated with incidence of COVID-19. Those who had received such a vaccination regimen were 56.0% less likely to be infected with Coronavirus 2019 than those who were not vaccinated, with statistical significance (ORadj = 0.44, 95% CI = 0.23-0.87, p = 0.017).
The results of this study provide important information for promoting COVID-19 vaccination. People can use this information to decide on heterologous prime-boost vaccination for prevention of COVID-19.
References
Cerqueira-Silva, T., Katikireddi, S. V., de Araujo Oliveira, V., Flores-Ortiz, R., Júnior, J. B., Paixão, E. S., Robertson, C., Penna, G. O., Werneck, G. L., Barreto, M. L., Pearce, N., Sheikh, A., Barral-Netto, M., & Boaventura, V. S. (2022). Vaccine effectiveness of heterologous CoronaVac plus BNT162b2 in Brazil. Nature Medicine, 28(4), 838–843.https://doi.org/10.1038/s41591-022-01701
Chuenjai, K., & Punturaumporn, B. (2021). Factors affecting the decision to vaccinate against Coronavirus (Covid-19) of the population in Bangkok. Faculty of Business Administration Program in Finance and Banking, Ramkhamhaeng University.
Cucinotta, D., & Vanelli, M. (2020). WHO declares COVID-19 a pandemic. Acta Biomed, 91(1), 157–160. https://doi.org/10.23750/abm.v91i1.9397
Filon, F. L., Rui, F., Ronchese, F., Michieli, P. D., & Negro, C. (2022). Incidence of COVID-19 infection in hospital workers from March 1, 2020 to May 31, 2021 routinely tested, before and after vaccination with BNT162B2. Scientific Reports.
Gu, T., Mack, J. A., Salvatore, M., Sankar, S. P., Valley, T. S., Singh, K., Nallamothu, B. K., Kheterpal, S., Lisabeth, L., Fritsche, L. G., & Mukherjee, B. (2020). COVID-19 outcomes, risk factors and associations by race: A comprehensive analysis using electronic health records data in Michigan Medicine. The Journal of the American Medical Association Network Open, 3(10), e2025197. https://doi.org/10.1101/2020.06.16.20133140
Immunization Subcommittee. (2021, August 25). COVID-19 vaccination as recommended for medical and public health personnel performing vaccination by the Immunization Sub-Committee. [The meeting of the Subcommittee on Immunization No. 5/2021]. Ministry of Public Health.
Kajhonlit, B., & Panthuramphorn, B. (2020). Factors affecting the decision making on Covid-19 vaccination among population in Samutprakarn Province [Unpublished doctoral dissertation]. Ramkhamhaeng University.
Khan, M. A., Khan, N., Mustagir, G., Rana, J., Islam, S., & Kabir, I. (2020). Effects of underlying morbidities on the occurrence of deaths in COVID-19 patients: A systematic review and meta-analysis. Journal of Global Health, 10(2), 020503. https://doi.org/10.7189/ jogh.10.020503
Ministry of Public Health. (2022a). Weekly COVID-19 patient situation. https://ddc.moph.go.th/covid19-daily-dashboard/? dashboard=analysis-province
Ministry of Public Health. (2022b). Summary of COVID-19 vaccination service results. https://ddc.moph.go.th/vaccine-covid19/getFiles/7/1664248847696.jpg
Ministry of Public Health. (2022c). Consideration of COVID-19 vaccination. https://ddc.moph.go.th/vaccine-covid19/getFiles/14/1651205056683.pdf
Moeradiothai. (2018). Eastern Lanna ethnic festival. http://www.moeradiothai.net/web/ news/detail/2890
Mukherjee, S., & Pahan, K. (2020). Is COVID-19 gender-sensitive? Journal of Neuroimmune Pharmacology, 16(1), 38-47. https://doi.org/10.1007/s11481-020-09974-z
Multimedia Department of Health. (2022). The 608 group is the group of people most in need of a COVID-19 vaccine. https://multimedia.anamai.moph.go.th/anamai-toons/covid-vaccine-4/
Nordstrom, P., Ballin, M., & Nordstrom, A. (2021). Effectiveness of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination against symptomatic Covid-19 infection in Sweden: A nationwide cohort study. https://doi.org/10.1016/j.lanepe.2021.100249
O'Driscoll, M., Santos, G. R. D., Wang, L., Cummings, D. A. T., Azman, A. S., Paireau, J., Fontanet, A., Cauchemez, S., & Salje, H. (2021). Age-specific mortality and immunity patterns of SARS-CoV-2. Nature, 590, 140–145. https://doi.org/10.1038/s41586-020-2918-0
Phayao Provincial Public Health Office. (2022). Situation of corona virus infection 2019 (Covid-19) Phayao Province. https://t.ly/fdKBf
Pienthong, T., Khawcharoenpor, T., Apisarnthanarak, P., Webe, D. J., & Apisarnthanarak, A. (2022). Factors associated with coronavirus disease 2019 (COVID-19) among Thai healthcare personnel with high-risk exposures: The important roles of double masking and physical distancing while eating. Infection Control & Hospital Epidemiology, 43(12), 1978-1980. https://doi.org/10.1017/ice.2022.58
Sathitakorn, O., Jantarathaneewat, K., Weber, D. J., Warren, D. K., & Apisarnthanarak, A. (2022). Factors associated with intensified infection prevention and vaccination practice among Thai health care personnel: A multicenter survey during COVID-19 pandemic. American Journal of Infection Control, 50(6), 704-706.
Schlesselman, J. J. (1982). Case-control studies design, conduct analysis. Oxford University Press.
Sritipsukho, P., Khawcharoenporn, T., Siribumrung, B., Damronglerd, P., Suwantarat, N., Satdhabudha, A., Chaiyakulsil, C., Sinlapamongkolkul, P., Tangsathapornpong, A., Bunjoungmanee, P., Nanthapisal, S., Tanprasertkul, C., Sritipsukho, N., Mingmalairak, C., Apisarnthanarak, A., & Tantiyavarong, P. (2022). Comparing real-life effectiveness of various COVID-19 vaccine regimens during the delta variant-dominant pandemic: A test-negative case-control study. Emerging Microbes & Infections, 11(1), 585-592.
Tragultaweesuk, P. (2022). Factors of influence COVID-19 vaccine intent and vaccine’s concerns among hospital staffs. Journal of Research and Health Innovative Development, 3(1). 47-57. https://he01.tci-thaijo.org/index.php/jrhi/article/view/ 253883/171317
Vokó, Z., Kiss, Z., Surján, G., Surján, O., Barcza, Z., Pályi, B., Formanek-Balku, E., Molnár, G. A., Herczeg, R., Gyenesei, A., Miseta, A., Kollár, L., Wittmann, I., Müller, C., & Kásler, M. (2021). Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungaryd the HUN-VE study. Clinical Microbiology and Infection, 28(3), 398-404.
Wanlapakorn, N., Suntronwong, N., Phowatthanasathian, H., Yorsang, R., Thongmee, T., Vichaiwattana, P., Auphimai, C., Wongsrisang, L., Klinfueng, S., Sudhinaraset, N., & Poovorawan, Y. (2021). Immunogenicity of heterologous inactivated and adenoviral-vectored COVID-19 vaccine: Real-world data. Vaccine, 40(23), 3203-3209. https://doi.org/10.1016/j.vaccine.2022.04.043
WHO. (2021). Interim recommendations for heterologous COVID-19 vaccine schedules; 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccines-SAGE-recommendation-heterologous-schedules?fbclid= IwAR0uuDAq8ra6E_ iQfIBq8ln1oHpkF6uJPqktyrKqQ8OJKcHxQuI-u3GRcEo
Zhou, Y., Yang, Q., Chi, J., Dong, B., Lv, W., Shen, L., & Wang, Y. (2020). Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: A systematic review and meta-analysis. International Journal of Infectious Diseases, 99, 47-56. https://doi.org/10.1016/j.ijid.2020.07.029
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Nursing Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
บทความที่ได้รับการตีพิมพ์เป็นลิขสิทธิ์ของวารสารพยาบาลสาร
ข้อความที่ปรากฏในบทความแต่ละเรื่องในวารสารวิชาการเล่มนี้เป็นความคิดเห็นส่วนตัวของผู้เขียนแต่ละท่านไม่เกี่ยวข้องกับมหาวิทยาลัยเชียงใหม่ และคณาจารย์ท่านอื่นๆในมหาวิทยาลัยฯ แต่อย่างใด ความรับผิดชอบองค์ประกอบทั้งหมดของบทความแต่ละเรื่องเป็นของผู้เขียนแต่ละท่าน หากมีความผิดพลาดใด ๆ ผู้เขียนแต่ละท่านจะรับผิดชอบบทความของตนเองแต่ผู้เดียว
